Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Last updated: 2021
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2021
- December 202113 results available
- November 202115 results available
- October 202115 results available
- September 202110 results available
- August 20217 results available
- July 202114 results available
- June 202120 results available
- May 202123 results available
- April 202116 results available
- March 202113 results available
- February 20217 results available
- January 202117 results available
Recall class
Displaying 136 - 150 of 170 items.
Recall of certain hand sanitizers that may pose health risks (Part 1 - June 17, 2020 to March 24, 2021)
AlertPublic advisory | 2021-03-24
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia
AlertHealth professional risk communication | 2021-03-24
Rhinaris Nasal Mist (2021-03-22)
RecallHealth product recall | 2021-03-22
Counterfeit respirators
AlertPublic advisory | 2021-03-19
Counterfeit 3M N95 respirators
AlertPublic advisory | 2021-03-19
Pfizer-BioNTech COVID-19 Vaccine: Updated Storage and Transportation Conditions
AlertHealth professional risk communication | 2021-03-08
Authorization of Janssen COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-08
Creatine Powder (2021-03-05)
RecallHealth product recall | 2021-03-05
Riva-Senna 8.6 mg(2021-03-03)
RecallHealth product recall | 2021-03-03
Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-01
Bull Wipes All-Purpose Disinfectant Wipes(2021-03-01)
RecallHealth product recall | 2021-03-01
NxStage PureFlow Solution(2021-02-26)
RecallHealth product recall | 2021-02-26
Creatine Powder (2021-02-20)
RecallHealth product recall | 2021-02-22
COVID-19 Vaccine Moderna: Updated English-only Global Vial and Carton Labels and Post-Market Adverse Reaction Information
AlertHealth professional risk communication | 2021-02-22
Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market Adverse Reaction Information
AlertHealth professional risk communication | 2021-02-09